ZA979984B - Vaccine composition - Google Patents

Vaccine composition

Info

Publication number
ZA979984B
ZA979984B ZA979984A ZA979984A ZA979984B ZA 979984 B ZA979984 B ZA 979984B ZA 979984 A ZA979984 A ZA 979984A ZA 979984 A ZA979984 A ZA 979984A ZA 979984 B ZA979984 B ZA 979984B
Authority
ZA
South Africa
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Application number
ZA979984A
Other languages
English (en)
Inventor
Patrick Florent
Jean Stephenne
Christian Vandecasserie
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA979984B publication Critical patent/ZA979984B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA979984A 1996-11-07 1997-11-06 Vaccine composition ZA979984B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition

Publications (1)

Publication Number Publication Date
ZA979984B true ZA979984B (en) 1998-07-23

Family

ID=10802615

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979984A ZA979984B (en) 1996-11-07 1997-11-06 Vaccine composition

Country Status (30)

Country Link
EP (2) EP1240905B3 (es)
JP (1) JP3980652B2 (es)
KR (1) KR100518044B1 (es)
CN (1) CN1130226C (es)
AR (1) AR011509A1 (es)
AT (2) ATE295178T1 (es)
AU (1) AU710475B2 (es)
BR (2) BRPI9712917B8 (es)
CA (1) CA2271008C (es)
CO (1) CO4910171A1 (es)
CY (2) CY2407B1 (es)
CZ (1) CZ295954B6 (es)
DE (3) DE69733285T3 (es)
DK (2) DK0941117T3 (es)
ES (2) ES2182131T3 (es)
GB (1) GB9623233D0 (es)
HK (2) HK1050473B (es)
HU (1) HU224126B1 (es)
IL (1) IL129530A (es)
LU (1) LU91183I2 (es)
NO (2) NO320186B1 (es)
NZ (1) NZ335384A (es)
PL (1) PL188460B1 (es)
PT (2) PT941117E (es)
SA (1) SA98181128B1 (es)
SI (2) SI1240905T1 (es)
TR (1) TR199900979T2 (es)
TW (1) TW471971B (es)
WO (1) WO1998019702A1 (es)
ZA (1) ZA979984B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (fr) * 1998-11-26 2000-05-31 Pasteur Merieux MSD Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
CA2772916C (en) 2009-09-02 2019-01-15 Novartis Ag Immunogenic compositions including tlr activity modulators
EA201390341A1 (ru) 2010-09-01 2013-08-30 Новартис Аг Адсорбция иммунопотенциаторов на нерастворимых солях металлов
KR20140026392A (ko) 2011-03-02 2014-03-05 노파르티스 아게 저용량의 항원 및/또는 보조제를 갖는 조합 백신
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
US9375471B2 (en) * 2012-03-08 2016-06-28 Glaxosmithkline Biologicals Sa Adjuvanted formulations of booster vaccines
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
US8916173B2 (en) 2013-03-08 2014-12-23 Crucell Holland B.V. Acellular pertussis vaccine
CN105555304A (zh) 2013-08-05 2016-05-04 葛兰素史密丝克莱恩生物有限公司 联合免疫原性组合物
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
AP56A (en) 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
EP1088830A3 (en) 1987-06-22 2004-04-07 Medeva Holdings B.V. Hepatitis b surface antigen particles
ES2056799T3 (es) 1987-07-17 1994-10-16 Rhein Biotech Ges Fur Biotechn Moleculas de adn codante para las regiones de control fmdh y gen estructural para una proteina que tiene una actividad de fmdh y su uso.
ES2109921T3 (es) 1989-07-25 1998-02-01 Smithkline Beecham Biolog Nuevos antigenos y procedimientos para su preparacion.
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
UA40596C2 (uk) 1992-05-23 2001-08-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини та спосіб її одержання

Also Published As

Publication number Publication date
JP3980652B2 (ja) 2007-09-26
ES2240647T3 (es) 2005-10-16
TW471971B (en) 2002-01-11
NO992156L (no) 1999-05-04
DE69715031T2 (de) 2003-05-08
NO2006005I1 (no) 2006-05-08
NO2006005I2 (no) 2010-04-12
ES2240647T7 (es) 2010-03-31
WO1998019702A1 (en) 1998-05-14
KR100518044B1 (ko) 2005-09-30
SI1240905T1 (en) 2005-10-31
CY2568B1 (en) 2008-07-02
PT1240905E (pt) 2005-09-30
HK1050473B (zh) 2006-03-03
BRPI9712917B8 (pt) 2021-05-25
IL129530A (en) 2005-11-20
CN1236321A (zh) 1999-11-24
DK1240905T5 (da) 2010-01-11
GB9623233D0 (en) 1997-01-08
HK1022638A1 (en) 2000-08-18
EP0941117A1 (en) 1999-09-15
DE69715031D1 (de) 2002-10-02
CA2271008C (en) 2008-07-22
NZ335384A (en) 2000-10-27
CZ295954B6 (cs) 2005-12-14
IL129530A0 (en) 2000-02-29
NO320186B1 (no) 2005-11-07
AU5319698A (en) 1998-05-29
ES2182131T3 (es) 2003-03-01
EP1240905B1 (en) 2005-05-11
DE69733285D1 (de) 2005-06-16
KR20000053092A (ko) 2000-08-25
DE69733285T3 (de) 2010-03-25
CO4910171A1 (es) 2000-04-24
BRPI9712917B1 (pt) 2019-12-03
EP0941117B1 (en) 2002-08-28
JP2001503422A (ja) 2001-03-13
PT941117E (pt) 2002-12-31
ATE295178T1 (de) 2005-05-15
PL188460B1 (pl) 2005-02-28
NO992156D0 (no) 1999-05-04
PL333127A1 (en) 1999-11-22
HU224126B1 (hu) 2005-05-30
EP1240905A1 (en) 2002-09-18
SA98181128B1 (ar) 2006-03-25
BR9712917A (pt) 1999-12-07
HUP9904287A3 (en) 2001-05-28
HUP9904287A1 (hu) 2000-04-28
CZ164099A3 (cs) 1999-10-13
HK1050473A1 (en) 2003-06-27
DK0941117T3 (da) 2002-11-18
TR199900979T2 (xx) 1999-07-21
AR011509A1 (es) 2000-08-30
CN1130226C (zh) 2003-12-10
SI0941117T1 (en) 2002-12-31
DE122005000046I1 (de) 2005-12-29
DK1240905T3 (da) 2005-07-18
AU710475B2 (en) 1999-09-23
CA2271008A1 (en) 1998-05-14
ATE222773T1 (de) 2002-09-15
DE69733285T2 (de) 2006-01-12
CY2407B1 (en) 2004-09-10
LU91183I2 (fr) 2005-09-20
EP1240905B3 (en) 2009-08-26

Similar Documents

Publication Publication Date Title
ZA978868B (en) Vaccine composition
CY2506B1 (en) Composition
PL343065A1 (en) Vaccine composition
GB9601398D0 (en) Composition
PL331424A1 (en) Antipaludian vaccine composition
EP0958373A4 (en) Vaccines.
ZA979984B (en) Vaccine composition
HU9600207D0 (en) Vaccine compositions
GB9605247D0 (en) Composition
EP0884044A4 (en) HAIR TREATMENT
GB9600604D0 (en) Composition
GB9602266D0 (en) Composition
ZA9711565B (en) Vaccine
GB9801870D0 (en) Vaccine composition
GB9625968D0 (en) Vaccine
GB9614618D0 (en) Vaccine compositions
GB9604585D0 (en) Composition
GB9622439D0 (en) Vaccine composition
GB9622438D0 (en) Vaccine composition
GB9622437D0 (en) Vaccine composition
ZA973824B (en) Vaccines
GB9625966D0 (en) Vaccine
GB9625967D0 (en) Vaccine
GB9601739D0 (en) Vaccine Compositions
GB9425980D0 (en) Vaccine compositions